Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria

Recent years have seen an unprecedented rise in the incidence of multidrug-resistant (MDR) Gram-negative bacteria (GNBs) such as Acinetobacter and Klebsiella species. In view of the shortage of novel drugs in the pipeline, alternative strategies to prevent, and treat infections by GNBs are urgently...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Youssef, Eman G., Zhang, Lina, Alkhazraji, Sondus, Gebremariam, Teclegiorgis, Singh, Shakti, Yount, Nannette Y., Yeaman, Michael R., Uppuluri, Priya, Ibrahim, Ashraf S.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7045048/
https://ncbi.nlm.nih.gov/pubmed/32153560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00076
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados